Skip to main content

Table 5 Studied variables of the subjects according to BMI categories

From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

  Body mass index (Kg/m2)
  BMI < 25 n = 263   25 ≤ BMI < 30 n = 245   BMI ≥ 30 n = 113
Age (Years) 44.0 (SD = 13.6)   51.4 (SD = 10.4)   52.4 (SD = 10.2)
p   <0.001   0.765  
Fasting glucose (mg/dl) 89.2 (SD = 10.9)   96.0 (SD = 15.8)   99.0 (SD = 14.8)
p   <0.001   0.132  
Total cholesterol (mg/dl) 198.2 (SD = 40.5)   210.4 (SD = 39.5)   211.1 (SD = 37.1)
p   0.001   0.986  
Triglycerides (mg/dl) 99.5 (SD = 55.1)   131.9 (SD = 81.0)   155.0 (SD = 120.8)
p   <0.001   0.032  
HDL-cholesterol (mg/dl) 62.7 (SD = 15.3)   56.1 (SD = 13.8)   55.4 (SD = 13.3)
p   <0.001   0.913  
Waist circumference (cm) 82.1 (SD = 9.7)   95.3 (SD = 8.9)   107.3 (SD = 11.0)
p   <0.001   <0.001  
SBP (mm Hg) 121.9 (SD = 15.3)   128.6 (SD = 15.7)   134.4 (SD = 15.8)
p   <0.001   0.003  
DBP (mm Hg) 74.3 (SD = 10.2)   78.6 (SD = 9.5)   80.1 (SD = 10.7)
p   <0.001   0.396  
CVRSCORE (%) 1.0 (SD = 1.3)   1.8 (SD = 2.1)   1.8 (SD = 2.0)
p   <0.001   0.991  
CVR REGICOR (%) 2.6 (SD = 1.7)   3.7 (SD = 2.5)   3.8 (SD = 2.4)
p   <0.001   0.964  
  1. p ≤ 0.05 is considered to be statistically significant.
  2. Data are expressed as means (Standard Deviation).
  3. BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular.